Catherine Perron

Catherine Perron

Auto-generated profile, based on publicly available information

Catherine Perron

École de travail social, Faculté des lettres et sciences humaines, Université de Sherbrooke, Sherbrooke, QC, Canada

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2022 in Healthcare Management Forum
Verified
Journal Article
Closed access
CPCatherine Perron
Catherine Perron
MBMarie-Eve Bouthillier
Marie-Eve Bouthillier
EREric Racine
Eric Racine
When the Act Respecting End-of-Life Care came into effect in Quebec in 2015, nearly 30 Interdisciplinary Support Groups (ISGs) were formed to accompany practitioners and managers in the clinical, administrative, legal, and ethical practice of Medical Assistance in Dying (MAiD). Today, significant variability is observed in the constitution, role and functioning of ISGs. Based on an overview of national and international support structures, we highlight the strengths and challenges of ISGs. This article presents the results of the first phase of research conducted with 245 people involved in the practice of MAiD in Quebec. The objective is to survey current ISG practices in order to contrast them with those of equivalent structures in Canada and around the world. The intention is to guide leaders in the development of support structures for their institutions. In summary, ISGs are distinguished by their interdisciplinary constitution, their decentralized nature, and their proximity to the teams in the field. However, their service offer remains largely unknown to caregivers and the general population. This can be explained by the undefined and unlimited nature of their mandate, but also by the gap between the scope of their mandate and the lack of funding they receive.

21 April 2026 in JMIR Research Protocols
Verified
Journal Article
Open access
IMIsabelle Marcoux
Isabelle Marcoux
DLDavid Lavoie
David Lavoie
ABAmy Bergeron
Amy Bergeron
ABAlexandra Beaudin
Alexandra Beaudin
SLSimon Lemyre
Simon Lemyre
MBMarie-Eve Bouthillier
Marie-Eve Bouthillier
Background: As of June 2025, medical assistance in dying (MAiD) is allowed in over 25 jurisdictions across 12 countries, with varying rates of requests and provision. Hypotheses have been suggested to explain these variations, but they are rarely backed up by empirical evidence. As more jurisdictions consider legalizing MAiD, it is important to better understand what factors may explain the evolution of the use of MAiD worldwide with a systematic approach. Objective: This scoping review aims to map the available evidence regarding the factors associated with the evolution of the use of MAiD in jurisdictions where it is allowed. Methods: The scoping review will follow the Joanna Briggs Institute methodology and the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews) guidelines. Ten electronic databases (including MEDLINE, Embase, CINAHL Complete, and APA PsycInfo) and additional gray literature sources will be searched from inception to the present. This scoping review will consider multiple types of publications (eg, primary studies, research syntheses, and government reports) and will report factors associated with the use of MAiD for people who have requested or died by MAiD in jurisdictions that have allowed it for at least 5 years. Publications in English, French, Spanish, German, or Dutch will be included. Screening for assessment against the inclusion criteria and data extraction will be carried out independently by pairs of reviewers. Findings will be presented in a narrative format and mapped into tables and graphs to address the review aims. Results: The database search for scientific publications was completed in March 2025. A total of 8570 publications were identified after removing duplicates. As of October 2025, title and abstract screening is complete, with 216 articles retained for the next stage. The full-text review is underway and scheduled to be completed by December 2025, and results are expected to be submitted for publication in 2026. Conclusions: MAiD is gaining legal and policy attention worldwide, with wide variation in rates of request and provision over time across jurisdictions. This scoping review will contribute to mapping and synthesizing evidence on the factors that may explain these variations.

20 October 2025 in JMIR Preprints
Verified
Preprint
Open access
IMIsabelle Marcoux
Isabelle Marcoux
DLDavid Lavoie
David Lavoie
ABAmy Bergeron
Amy Bergeron
ABAlexandra Beaudin
Alexandra Beaudin
SLSimon Lemyre
Simon Lemyre
MBMarie-Eve Bouthillier
Marie-Eve Bouthillier
BACKGROUND As of June 2025, Medical Assistance in Dying (MAiD) is allowed in over 25 jurisdictions across 12 countries, with varying rates of requests and provisions. Hypotheses have been suggested to explain these variations, but they are rarely backed up by empirical evidence. As more jurisdictions consider legalizing MAiD, it is important to better understand what factors may explain the evolution in the use of MAiD around the world with a systematic approach. OBJECTIVE This scoping review aims to map the available evidence regarding the factors associated with the evolution in the use of MAiD in jurisdictions where such practices are allowed. METHODS The scoping review will follow the Joanna Briggs Institute (JBI) methodology and the PRISMA-ScR guidelines. Ten electronic databases (including MEDLINE, Embase, CINAHL Complete, and APA PsycInfo) and additional grey literature sources will be searched from inception to present. This scoping review will consider multiple types of publications (eg, primary studies, research syntheses, government reports) reporting factors associated with the use of MAiD for people who have requested or died by MAiD in jurisdictions that have allowed it for at least 5 years. Publications in English, French, Spanish, German, or Dutch will be included. Screening for assessment against the inclusion criteria and data extraction will be carried out independently by pairs of reviewers. Findings will be presented in a narrative format, mapped into tables and graphs, and thematically synthetized to address the review aims. RESULTS The database search for scientific publications was completed on March 2025. A total of 8570 publications were identified after removing duplicates. As of October 2025, title and abstract screening is complete, with 216 articles retained for the next stage. The full-text review is underway, and results are expected to be submitted for publication in 2026. CONCLUSIONS MAiD is gaining legal and policy attention globally, with wide variation in rates of request and provision over time across jurisdictions. This scoping review will contribute to mapping and synthesizing evidence on the factors that may explain these variations. CLINICALTRIAL OSF Registries osf.io/tknam ; https://osf.io/tknam

20 April 2026 in JMIR Research Protocols
Verified
Journal Article
Open access
MBMarie-Eve Bouthillier
Marie-Eve Bouthillier
IMIsabelle Marcoux
Isabelle Marcoux
CPCatherine Perron
Catherine Perron
BGBruno Gagnon
Bruno Gagnon
DLDavid Lussier
David Lussier
JDJacinthe Dupuis
Jacinthe Dupuis
Background: Medical assistance in dying (MAiD) became a legal end-of-life option on December 10, 2015, in Québec, and on June 17, 2016, in the rest of Canada. Since its legalization, there has been a steady increase in the number of MAiD requests and provisions. Across permissive jurisdictions, Québec now has the highest rate of assisted death. Despite the growing use of MAiD, research examining the factors driving this increase remains limited and fragmented. Existing studies offer partial and sometimes contradictory explanations, with little integration of legal, institutional, societal, and individual dimensions. Further research is needed to better understand the determinants of MAiD requests and practices, particularly in the Canadian and Québec contexts. Objective: This research aims to understand the factors influencing changes in MAiD requests and administrations in Québec by examining laws, practices, societal perspectives, organization of care and services, and individual characteristics of those requesting MAiD, as well as their interrelationships. We present the protocol developed by the Consortium interdisciplinaire de recherche sur l'aide médicale à mourir, an interdisciplinary research consortium, including an international advisory committee, set up for this research. Methods: The design of this protocol is multimethods and convergent mixed methods, including (1) an international cross-thematical approach with 4 main research methods (a scoping review, key informant interviews, focus groups with health care professionals, and a population-based survey) chosen to partially answer research questions across the entire study and to compare with other jurisdictions and (2) 11 theme-specific methods (including community forums, media coverage analysis, comparative legal analyses, case studies of triads, individual interviews, and system mapping) to enrich and complement findings from the cross-thematical approach. Results: When this 3-year funded study started in July 2024, several research methods not requiring ethics committee approval (because no human participants were involved) were initiated, including scoping and systematic reviews, media coverage analysis, and comparative legal analyses. By August 2025, interviews with key informants were completed, and analyses took place in September. Concurrently, other subteams started data collection (focus groups December 2025) or are getting ready to seek ethics approval for their protocols and data collection processes involving human participants: case studies of triads, individual interviews, and community forums. Conclusions: Findings from the international cross-thematical approach and theme-specific methods will provide a comprehensive understanding of the factors influencing the use of MAiD in Québec. This study has strengths, including the use of a specific theoretical framework, a variety of complementary methods, and an integrated knowledge mobilization strategy. As for its limitations, we foresee challenges with the comparison of jurisdictions in terms of language, culture, and legal systems, as well as access to data about MAiD cases, since reporting systems may differ between jurisdictions. International Registered Report Identifier (IRRID): DERR1-10.2196/83549

29 July 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
JDJocelyn Downie
Jocelyn Downie
SGStefanie Green
Stefanie Green
ECEliana Close
Eliana Close
ACAmanda Cramm
Amanda Cramm
JDJames Downar
James Downar
CRChristopher Riddle
Christopher Riddle
In the context of this special issue of the Canadian Journal of Bioethics that seeks to present an accurate and honest picture of MAiD in Canada as experienced by those who live it from the inside, this paper takes a step back and asks the question “how could Canada’s MAiD system be improved?” We brought together authors of this special issue for an in-person roundtable discussion of the topic of this paper. Prior to the meeting, all members of the group were invited to respond to a series of preparatory questions generated by the two lead co-authors after a review of the literature and their own reflections. These responses informed and structured the subsequent roundtable discussion and collaborative iterative generation of this paper. We limit the scope to concerns that are specific to MAiD (although sometimes not exclusive to it) rather than those that apply broadly to the entire health care system. We also do not cover concerns that are fully addressed elsewhere in this special issue (e.g., institutional refusals to allow MAiD and attempted family override of patient wishes. We focus on those concerns about how the MAiD system is currently functioning that, if addressed, could have the greatest positive impact on patients and their loved ones in Canada, specifically, 4 issues: raising the topic of MAiD, Track 1 and Track 2 misassignments; MAiD coordination systems; and oversight of MAiD. In an effort to constructively respond to our concerns, we also reflect on the causes and consequences of those concerns before offering some course corrections.

20 July 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
CPCatherine Perron
Catherine Perron
This article examines the ethical, clinical, and policy implications of institutional refusals to allow Medical Assistance in Dying (MAiD) in Canada. In most provinces, governments adopt a stance of non-interference, neither prohibiting these refusals nor mitigating their consequences. This allows practices that compromise patient well-being, particularly through forced transfers of eligible individuals who wish to receive MAiD services. Empirical research, regulatory reports, and recent litigation in Quebec and British Columbia show that these refusals generate avoidable harms. Quebec offers a dual model combining state regulation-mandating MAiD availability in all healthcare institutions, including palliative care hospices-with institutional selfregulation, two strategies that have significantly reduced transfers. The article challenges claims that forced transfers are too rare to warrant policy reform. Such transfers are not exceptional and can have serious consequences. For patients, they may delay care, intensify suffering, cause loss of capacity, and disrupt relational continuity. Families face logistical burdens, stigma, moral distress, and complicated grieving, while healthcare professionals report ethical conflicts and frustration when enforcing policies they judge clinically or morally inappropriate. These transfers act as sentinel events, revealing structural weaknesses and tensions between institutional values, professional practice, and patient rights. Two concepts shed light on these dynamics: the "paradox of conscience," where protecting an institution's moral identity compromises patient autonomy, and the "disproportionate harm" where patients are exposed to avoidable risks whose magnitude exceeds the ethical justification for institutional refusal. In conclusion, the evidence indicates that tolerating institutional refusals in publicly funded systems is ethically indefensible. Equitable access to MAiD requires proactive governmental action. Letting non-interference dictate forced transfer practices produces a form of indifference toward patients, families, and healthcare teams, who are left to bear the human cost of this (non)decision alone.